Mark J Alles
CIK 1538897 · CEO, CHAIRMAN OF BOARD · last filed 2023-09-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$844.6K
Companies
4
Total Filings
71
Lifetime Open-Market Net
-$28.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Director | 3,666 | $0.00 | $1 | $88.6K | 8 | 2023-09-19 |
| BMRN | Director | 15,095 | $55.95 | $844.6K | $314.5K | 4 | 2023-05-24 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | 0 | $76.01 | $0 | $162.7K | 4 | 2022-08-17 |
| CELGENE CORP /DE/ (CELGZ) Delisted | CEO, CHAIRMAN OF BOARD | 292,081 | — | — | -$28.64M | 55 | 2019-11-22 |
Recent Filings · Page 2 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-10 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-26 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2020-05-13 | SYRS | Buy (P) | +10,000 | $88.6K | EDGAR |
| 2019-12-20 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2019-11-22 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | −227,518 | $0 | EDGAR |
| 2019-11-22 | CELGENE CORP /DE/ (CELGZ) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-05-06 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +8,988 | -$630.3K | EDGAR |
| 2019-03-05 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +19,909 | -$1.19M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.